- Home
- IT vs IQV Comparison
IT vs IQV Comparison
Compare IT & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IT
- IQV
- Stock Information
- Founded
- IT 1979
- IQV 1982
- Country
- IT United States
- IQV United States
- Employees
- IT N/A
- IQV N/A
- Industry
- IT Other Consumer Services
- IQV Biotechnology: Commercial Physical & Biological Resarch
- Sector
- IT Consumer Discretionary
- IQV Health Care
- Exchange
- IT Nasdaq
- IQV Nasdaq
- Market Cap
- IT 41.9B
- IQV 35.7B
- IPO Year
- IT 1993
- IQV 2013
- Fundamental
- Price
- IT $487.55
- IQV $190.98
- Analyst Decision
- IT Buy
- IQV Strong Buy
- Analyst Count
- IT 7
- IQV 17
- Target Price
- IT $555.71
- IQV $251.00
- AVG Volume (30 Days)
- IT 479.3K
- IQV 1.4M
- Earning Date
- IT 02-04-2025
- IQV 02-06-2025
- Dividend Yield
- IT N/A
- IQV N/A
- EPS Growth
- IT 44.40
- IQV 2.74
- EPS
- IT 16.00
- IQV 7.49
- Revenue
- IT $6,267,411,000.00
- IQV $15,405,000,000.00
- Revenue This Year
- IT $9.89
- IQV $5.17
- Revenue Next Year
- IT $8.96
- IQV $6.04
- P/E Ratio
- IT $30.49
- IQV $25.51
- Revenue Growth
- IT 6.10
- IQV 2.81
- 52 Week Low
- IT $411.15
- IQV $187.62
- 52 Week High
- IT $584.01
- IQV $261.73
- Technical
- Relative Strength Index (RSI)
- IT 29.50
- IQV 37.76
- Support Level
- IT $507.30
- IQV $192.10
- Resistance Level
- IT $517.06
- IQV $198.90
- Average True Range (ATR)
- IT 12.97
- IQV 5.43
- MACD
- IT -5.40
- IQV -1.28
- Stochastic Oscillator
- IT 1.72
- IQV 0.75
About IT Gartner Inc.
Gartner Inc provides independent research and analysis on information technology and other related technology industries. Its research is delivered to clients' desktops in the form of reports, briefings, and updates. Typical clients are chief information officers and other business executives who help plan companies' IT budgets. Gartner also provides consulting services. The Company operates through three business segments, namely Research, Conferences and Consulting. The company generates majority of the revenue from Research segment.
About IQV IQVIA Holdings Inc.
IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.